DPP9
Basic information
Region (hg38): 19:4674341-4724673
Links
Phenotypes
GenCC
Source:
- hatipoglu immunodeficiency syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Hatipoglu immunodeficiency syndrome | AR | Allergy/Immunology/Infectious | The condition can include susceptibility to infection, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; HSCT has been described | Allergy/Immunology/Infectious; Craniofacial; Dermatologic; Musculoskeletal; Neurologic | 36112693 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (126 variants)
- not_provided (21 variants)
- Hatipoglu_immunodeficiency_syndrome (11 variants)
- Susceptibility_to_severe_COVID-19 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DPP9 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000139159.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 15 | ||||
| missense | 123 | 136 | ||||
| nonsense | 3 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 2 | 4 | 124 | 19 | 6 |
Highest pathogenic variant AF is 0.0000055776873
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DPP9 | protein_coding | protein_coding | ENST00000262960 | 20 | 49450 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.987 | 0.0129 | 124627 | 0 | 13 | 124640 | 0.0000522 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.66 | 379 | 555 | 0.682 | 0.0000365 | 5802 |
| Missense in Polyphen | 138 | 234.38 | 0.58879 | 2483 | ||
| Synonymous | -0.249 | 254 | 249 | 1.02 | 0.0000191 | 1676 |
| Loss of Function | 5.38 | 8 | 48.4 | 0.165 | 0.00000249 | 532 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000152 | 0.000152 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000464 | 0.0000464 |
| European (Non-Finnish) | 0.0000730 | 0.0000619 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Dipeptidyl peptidase that cleaves off N-terminal dipeptides from proteins having a Pro or Ala residue at position 2.;
- Pathway
- Lung fibrosis
(Consensus)
Recessive Scores
- pRec
- 0.179
Intolerance Scores
- loftool
- 0.465
- rvis_EVS
- -0.8
- rvis_percentile_EVS
- 12.53
Haploinsufficiency Scores
- pHI
- 0.389
- hipred
- Y
- hipred_score
- 0.768
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.984
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dpp9
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); digestive/alimentary phenotype;
Gene ontology
- Biological process
- proteolysis
- Cellular component
- nucleus;cytosol
- Molecular function
- aminopeptidase activity;serine-type peptidase activity;identical protein binding